BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Relapsed or Refractory Mature T-and NK-Cell Lymphomas
Charbone Hydrogene Annonce un Financement de Reglements de Dettes par Emission d'Unites pour un Montant Total de 1,3M$
Cartier Signs Agreement with Exploits Discovery To Option 100% of the Benoist, Fenton and Wilson Properties Â
